Topics

DCL05, an AI-guided degrader, eliminates the CLIP1-LTK fusion protein at 40 picomolar — clearing both kinase and scaffolding functions that standard inhibitors miss.

UCLA researchers discovered that creatine fuels the immune system's cancer-fighting command cells, opening a surprising new avenue for future immunotherapies.

UBC Okanagan scientists have unlocked the enzymatic pathway behind mitraphylline, a rare plant‑based anticancer molecule, enabling a sustainable production route for future therapies.